Hisse Senetlerindeki Sıralama
#2843
CG Oncology, Inc., a late-stage clinical biopharmaceutical company, develops... CG Oncology, Inc., a late-stage clinical biopharmaceutical company, develops and commercializes cretostimogene grenadenorepvec for patients with bladder cancer in the United States. The company’s product candidate is cretostimogene, an investigational oncolytic immunotherapy, which is in phase 2 clinical trials of cretostimogene in patients with high-risk NMIBC after BCG failure; a phase 3 clinical trials to evaluate the safety and efficacy of cretostimogene as monotherapy in the treatment of patients who have received adequate BCG therapy with high-risk BCG-unresponsive, CIS-containing NMIBC and BCG-unresponsive Ta, or T1 papillary tumors; phase 3 BOND-003 Cohort C trials as a single agent; phase 3 BOND-003 Cohort P as a single agent in patients with BCG-UR papillary-only NMIBC. It also develops cretostimogene monotherapy for intermediate-risk NMIBC following TURBT, which is in phase 3 PIVOT-006 clinical trials to assess the safety and efficacy of adjuvant cretostimogene; and cretostimogene monotherapy for high-risk NMIBC in phase 2 CORE-008 clinical trials to assess the safety and clinical outcomes of cretostimogene in treating patients with high-risk NMIBC, including BCG-exposed and BCG-naïve NMIBC. The company was formerly known as Cold Genesys, Inc. and changed its name to CG Oncology, Inc. in June 2020. CG Oncology, Inc. was founded in 2010 and is headquartered in Irvine, California.
Ticaret CG Oncology Inc. (CGON)
B piyasa değeri ile CGON fiyatı
Piyasa Değeri CG Oncology Inc.(CGON)
Piyasa Değeri: $6.96B
August 2026 itibarıyla CG Oncology Inc. şirketinin piyasa değeri $6.96B. Bu, verilerimize göre CG Oncology Inc. şirketini dünyanın en değerli 2843rd. şirketi yapar. Piyasa değeri, halka açık bir şirketin tedavüldeki hisse senetlerinin toplam piyasa değeri olup, bir şirketin değerini ölçmek için yaygın olarak kullanılır.
CG Oncology Inc. piyasa değeri geçmişi (2024 - 2026)
En Popüler 5 stocks ile karşılaştırıldığında CGON
| CGON’in Fiyatı |
|
B Varlığı |
B’nin Piyasa Değeri |
Sonuçlar |
|
|
|
|
$5.152T
|
+73,976.74%
|
|
|
|
|
$4.537T
|
+65,128.25%
|
|
|
|
|
$4.169T
|
+59,831.04%
|
|
|
|
|
$3.642T
|
+52,265.67%
|
|
|
|
|
$2.805T
|
+40,222.92%
|
